BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:BLCO - CA0717051076 - Common Stock
17.08 USD
-0.08 (-0.47%)
17.08 USD
0 (0%)
BLCO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. While BLCO is still in line with the averages on profitability rating, there are concerns on its financial health. BLCO has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BLCO was profitable.
BLCO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
BLCO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BLCO has a Return On Assets of -2.21%. This is in the better half of the industry: BLCO outperforms 69.89% of its industry peers.
BLCO has a Return On Equity of -4.74%. This is in the better half of the industry: BLCO outperforms 70.43% of its industry peers.
BLCO has a Return On Invested Capital of 0.77%. This is in the better half of the industry: BLCO outperforms 66.13% of its industry peers.
BLCO had an Average Return On Invested Capital over the past 3 years of 1.59%. This is significantly below the industry average of 8.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROIC | 0.77% |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
1.3 Margins
The Operating Margin of BLCO (2.33%) is better than 67.74% of its industry peers.
In the last couple of years the Operating Margin of BLCO has declined.
Looking at the Gross Margin, with a value of 59.45%, BLCO is in line with its industry, outperforming 59.14% of the companies in the same industry.
In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.33% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% |
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCO is destroying value.
The number of shares outstanding for BLCO has been increased compared to 1 year ago.
BLCO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BLCO has a worse debt to assets ratio.
2.2 Solvency
BLCO has an Altman-Z score of 0.87. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
BLCO's Altman-Z score of 0.87 is in line compared to the rest of the industry. BLCO outperforms 51.08% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that BLCO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.77, BLCO is doing worse than 69.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.87 |
ROIC/WACC0.1
WACC7.47%
2.3 Liquidity
A Current Ratio of 1.51 indicates that BLCO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.51, BLCO is doing worse than 73.12% of the companies in the same industry.
BLCO has a Quick Ratio of 1.51. This is a bad value and indicates that BLCO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.98, BLCO is doing worse than 76.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The earnings per share for BLCO have decreased strongly by -29.51% in the last year.
Looking at the last year, BLCO shows a small growth in Revenue. The Revenue has grown by 6.23% in the last year.
Measured over the past years, BLCO shows a small growth in Revenue. The Revenue has been growing by 4.87% on average per year.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
3.2 Future
Based on estimates for the next years, BLCO will show a very strong growth in Earnings Per Share. The EPS will grow by 22.03% on average per year.
Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 4.98% on average per year.
EPS Next Y-10.98%
EPS Next 2Y13.37%
EPS Next 3Y20.28%
EPS Next 5Y22.03%
Revenue Next Year6.46%
Revenue Next 2Y6.13%
Revenue Next 3Y5.92%
Revenue Next 5Y4.98%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
BLCO is valuated quite expensively with a Price/Earnings ratio of 39.72.
BLCO's Price/Earnings ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 69.89% of the companies in the same industry.
When comparing the Price/Earnings ratio of BLCO to the average of the S&P500 Index (26.51), we can say BLCO is valued slightly more expensively.
A Price/Forward Earnings ratio of 21.43 indicates a rather expensive valuation of BLCO.
Based on the Price/Forward Earnings ratio, BLCO is valued cheaper than 80.11% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. BLCO is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.72 | ||
| Fwd PE | 21.43 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BLCO is valued a bit cheaper than 76.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 19.65 |
4.3 Compensation for Growth
BLCO's earnings are expected to grow with 20.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.37%
EPS Next 3Y20.28%
5. Dividend
5.1 Amount
No dividends for BLCO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
17.08
-0.08 (-0.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.05%
Inst Owner Change7.26%
Ins Owners0.45%
Ins Owner Change2.16%
Market Cap6.05B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72
Price Target17.34 (1.52%)
Short Float %8.17%
Short Ratio7.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.31%
PT rev (3m)10.59%
EPS NQ rev (1m)-1.52%
EPS NQ rev (3m)-4.39%
EPS NY rev (1m)0.68%
EPS NY rev (3m)2.3%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.72 | ||
| Fwd PE | 21.43 | ||
| P/S | 1.22 | ||
| P/FCF | N/A | ||
| P/OCF | 35.8 | ||
| P/B | 0.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.65 |
EPS(TTM)0.43
EY2.52%
EPS(NY)0.8
Fwd EY4.67%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.48
OCFY2.79%
SpS14.05
BVpS18.15
TBVpS-4.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROCE | 0.97% | ||
| ROIC | 0.77% | ||
| ROICexc | 0.79% | ||
| ROICexgc | 2.52% | ||
| OM | 2.33% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% | ||
| FCFM | N/A |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
ROICexc(3y)1.64%
ROICexc(5y)1.97%
ROICexgc(3y)5.47%
ROICexgc(5y)6.76%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.05 | ||
| Cap/Depr | 85.28% | ||
| Cap/Sales | 7.34% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 31.07% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.87 |
F-Score4
WACC7.47%
ROIC/WACC0.1
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-10.98%
EPS Next 2Y13.37%
EPS Next 3Y20.28%
EPS Next 5Y22.03%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.46%
Revenue Next 2Y6.13%
Revenue Next 3Y5.92%
Revenue Next 5Y4.98%
EBIT growth 1Y-38.95%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year46.23%
EBIT Next 3Y23.44%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%
BAUSCH + LOMB CORP / BLCO FAQ
What is the fundamental rating for BLCO stock?
ChartMill assigns a fundamental rating of 3 / 10 to BLCO.
What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?
ChartMill assigns a valuation rating of 3 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Overvalued.
Can you provide the profitability details for BAUSCH + LOMB CORP?
BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.
What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?
The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.